ODT vs. IR [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2014-03-10 20:36 (4489 d 23:39 ago) – Posting: # 12587
Views: 4,471

Dear mittyri
You are right, this inconsistency is confusing. But you will find something similar also in the guideline for MR products (draft). On the one hand the EMA would like to see a study to assess the food effect (MR) or the effect of water (your case) and on the other hand EMA commits that this effect doesn't matter as long as you are bioequivalent in a simple 2 way cross over (or two 2 way for MR). My suggestion is to conduct the simple study and to discuss arguments which led to the refusal of the 3 way study in modul 2.5 Clinical Overview of the dossier.
I hope this helps
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
171 visitors (0 registered, 171 guests [including 31 identified bots]).
Forum time: 21:16 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5